EMG Biosensors Market Size

EMG Biosensors Market size is poised to reach USD 2 Billion by the end of 2036, growing at a CAGR of 9% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of EMG biosensors was USD 625 Million. The reason behind the growth is impelled by increasing cases of musculoskeletal disorders. Musculoskeletal disorders are the main cause of disability, brought on by biomechanical stress, and bodily reaction, overexertion, or repetitive motion. According to the World Health Organization (WHO), musculoskeletal disorders affect about 1.71 billion individuals across the globe.

The growing technological advancements in EMG biosensors are believed to fuel the market growth. For instance, there are now more opportunities for human–machine interfaces (HMI) employing EMG sensors as they can be used in a variety of industries, including virtual reality interfaces, prosthetics, and rehabilitation to give constant signal data, making it possible to track muscle activation in real-time and to predict and classify user movements.

Frequently Asked Questions (FAQ)

Increasing cases of musculoskeletal disorders and the growing technological advancements in EMG biosensors are the major factors driving the growth of the market.

The market size of EMG biosensors is anticipated to attain a CAGR of 9% over the forecast period, i.e., 2024-2036.

The major players in the market are OpenBCI Inc., Multi Biosensors Inc., Innopsys Inc., Biometrics Ltd., Butler Technologies, Inc., mDurance Solutions SL., iMotions A/S, Delsys Incorporated, Pinnacle Technology, and others.

The hospitals and clinics segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

EMG Biosensors Market Size